The page is the record's research on the issuer — no analyst, no rating, no view. # CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is CNS Pharmaceuticals, Inc., listed on NASDAQ under ticker CNSP, with ISIN US18978H5081 and LEI 529900FDJ7WGF2Q7UN44. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Nevada. Its listing status is listed, not halted. ## The disclosure read The record holds 45 filings across 29 filing days in the twelve months from 2025-11-08 to 2026-11-08. The median gap between filing days is 4.0 days, and the latest filing is 37 days before the record date of 2026-11-08. The latest filing is of type director_change, dated 2026-10-02. The NASDAQ median is 52 filings, a median gap of 6.0 days, and a median latency of 5.0 days across 4,359 issuers. The sector median is 63.0 filings, a median gap of 6.0 days, and a median latency of 4.0 days across 526 issuers. ## Auditor The auditor of record is MaloneBailey, LLP, located in Houston, Texas. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with an earliest sealed date of 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://data.sec.gov/submissions/CIK0001729427.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/CNSP (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1729427/000168316826002550/cns_i10k-123125.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/CNSP (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CNSP · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp